- Home
- SRFM vs ANVS Comparison
SRFM vs ANVS Comparison
Compare SRFM & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRFM
- ANVS
- Stock Information
- Founded
- SRFM 2011
- ANVS 2008
- Country
- SRFM United States
- ANVS United States
- Employees
- SRFM N/A
- ANVS N/A
- Industry
- SRFM Transportation Services
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- SRFM Consumer Discretionary
- ANVS Health Care
- Exchange
- SRFM Nasdaq
- ANVS Nasdaq
- Market Cap
- SRFM 58.2M
- ANVS 54.6M
- IPO Year
- SRFM 2023
- ANVS 2020
- Fundamental
- Price
- SRFM $1.95
- ANVS $2.64
- Analyst Decision
- SRFM Strong Buy
- ANVS Strong Buy
- Analyst Count
- SRFM 3
- ANVS 5
- Target Price
- SRFM $6.42
- ANVS $30.25
- AVG Volume (30 Days)
- SRFM 778.7K
- ANVS 570.5K
- Earning Date
- SRFM 08-13-2025
- ANVS 08-14-2025
- Dividend Yield
- SRFM N/A
- ANVS N/A
- EPS Growth
- SRFM N/A
- ANVS N/A
- EPS
- SRFM N/A
- ANVS N/A
- Revenue
- SRFM $112,307,000.00
- ANVS N/A
- Revenue This Year
- SRFM N/A
- ANVS N/A
- Revenue Next Year
- SRFM $62.23
- ANVS N/A
- P/E Ratio
- SRFM N/A
- ANVS N/A
- Revenue Growth
- SRFM 31.17
- ANVS N/A
- 52 Week Low
- SRFM $0.90
- ANVS $1.11
- 52 Week High
- SRFM $6.72
- ANVS $17.88
- Technical
- Relative Strength Index (RSI)
- SRFM 39.50
- ANVS 54.28
- Support Level
- SRFM $1.91
- ANVS $2.73
- Resistance Level
- SRFM $2.48
- ANVS $3.08
- Average True Range (ATR)
- SRFM 0.24
- ANVS 0.32
- MACD
- SRFM -0.04
- ANVS -0.06
- Stochastic Oscillator
- SRFM 13.59
- ANVS 29.41
About SRFM Surf Air Mobility Inc.
Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.